rs1538660

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003640.5(ELP1):​c.3473C>T​(p.Pro1158Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.181 in 1,611,346 control chromosomes in the GnomAD database, including 28,307 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. P1158P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.22 ( 4006 hom., cov: 32)
Exomes 𝑓: 0.18 ( 24301 hom. )

Consequence

ELP1
NM_003640.5 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 3.18

Publications

40 publications found
Variant links:
Genes affected
ELP1 (HGNC:5959): (elongator acetyltransferase complex subunit 1) The protein encoded by this gene is a scaffold protein and a regulator for three different kinases involved in proinflammatory signaling. The encoded protein can bind NF-kappa-B-inducing kinase and I-kappa-B kinases through separate domains and assemble them into an active kinase complex. Mutations in this gene have been associated with familial dysautonomia. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2016]
ELP1 Gene-Disease associations (from GenCC):
  • primary dysautonomia
    Inheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health
  • Riley-Day syndrome
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • medulloblastoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004501313).
BP6
Variant 9-108879545-G-A is Benign according to our data. Variant chr9-108879545-G-A is described in ClinVar as Benign. ClinVar VariationId is 259113.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.313 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ELP1NM_003640.5 linkc.3473C>T p.Pro1158Leu missense_variant Exon 33 of 37 ENST00000374647.10 NP_003631.2 O95163Q4LE38Q8N516
ELP1NM_001318360.2 linkc.3131C>T p.Pro1044Leu missense_variant Exon 33 of 37 NP_001305289.1 O95163A0A6Q8PGW3B4E3I9
ELP1NM_001330749.2 linkc.2426C>T p.Pro809Leu missense_variant Exon 31 of 35 NP_001317678.1 F5H2T0B3KNB2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ELP1ENST00000374647.10 linkc.3473C>T p.Pro1158Leu missense_variant Exon 33 of 37 1 NM_003640.5 ENSP00000363779.5 O95163

Frequencies

GnomAD3 genomes
AF:
0.217
AC:
33017
AN:
151832
Hom.:
4003
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.318
Gnomad AMI
AF:
0.275
Gnomad AMR
AF:
0.162
Gnomad ASJ
AF:
0.223
Gnomad EAS
AF:
0.294
Gnomad SAS
AF:
0.229
Gnomad FIN
AF:
0.184
Gnomad MID
AF:
0.204
Gnomad NFE
AF:
0.167
Gnomad OTH
AF:
0.199
GnomAD2 exomes
AF:
0.194
AC:
48749
AN:
250972
AF XY:
0.194
show subpopulations
Gnomad AFR exome
AF:
0.318
Gnomad AMR exome
AF:
0.143
Gnomad ASJ exome
AF:
0.223
Gnomad EAS exome
AF:
0.287
Gnomad FIN exome
AF:
0.187
Gnomad NFE exome
AF:
0.167
Gnomad OTH exome
AF:
0.193
GnomAD4 exome
AF:
0.177
AC:
258332
AN:
1459392
Hom.:
24301
Cov.:
31
AF XY:
0.179
AC XY:
129759
AN XY:
726126
show subpopulations
African (AFR)
AF:
0.323
AC:
10799
AN:
33412
American (AMR)
AF:
0.147
AC:
6574
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.221
AC:
5765
AN:
26120
East Asian (EAS)
AF:
0.323
AC:
12823
AN:
39676
South Asian (SAS)
AF:
0.223
AC:
19213
AN:
86214
European-Finnish (FIN)
AF:
0.188
AC:
10032
AN:
53398
Middle Eastern (MID)
AF:
0.185
AC:
1065
AN:
5760
European-Non Finnish (NFE)
AF:
0.163
AC:
180606
AN:
1109802
Other (OTH)
AF:
0.190
AC:
11455
AN:
60290
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
10312
20624
30936
41248
51560
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6522
13044
19566
26088
32610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.217
AC:
33039
AN:
151954
Hom.:
4006
Cov.:
32
AF XY:
0.218
AC XY:
16182
AN XY:
74226
show subpopulations
African (AFR)
AF:
0.318
AC:
13170
AN:
41438
American (AMR)
AF:
0.161
AC:
2462
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.223
AC:
772
AN:
3466
East Asian (EAS)
AF:
0.293
AC:
1505
AN:
5140
South Asian (SAS)
AF:
0.229
AC:
1101
AN:
4814
European-Finnish (FIN)
AF:
0.184
AC:
1942
AN:
10536
Middle Eastern (MID)
AF:
0.214
AC:
63
AN:
294
European-Non Finnish (NFE)
AF:
0.167
AC:
11358
AN:
67974
Other (OTH)
AF:
0.197
AC:
416
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1285
2569
3854
5138
6423
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
342
684
1026
1368
1710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.188
Hom.:
9054
Bravo
AF:
0.220
TwinsUK
AF:
0.160
AC:
594
ALSPAC
AF:
0.172
AC:
663
ESP6500AA
AF:
0.303
AC:
1333
ESP6500EA
AF:
0.165
AC:
1423
ExAC
AF:
0.198
AC:
24067
Asia WGS
AF:
0.274
AC:
951
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Familial dysautonomia Benign:3
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

May 10, 2017
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.062
BayesDel_addAF
Benign
-0.61
T
BayesDel_noAF
Benign
-0.50
CADD
Benign
13
DANN
Benign
0.79
DEOGEN2
Benign
0.12
T;T
Eigen
Benign
-0.67
Eigen_PC
Benign
-0.58
FATHMM_MKL
Benign
0.73
D
LIST_S2
Benign
0.54
T;T
MetaRNN
Benign
0.0045
T;T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
1.7
L;.
PhyloP100
3.2
PrimateAI
Benign
0.26
T
PROVEAN
Benign
-1.4
N;N
REVEL
Benign
0.045
Sift
Benign
0.72
T;T
Sift4G
Benign
0.82
T;T
Polyphen
0.0020
B;.
Vest4
0.084
MPC
0.074
ClinPred
0.0018
T
GERP RS
3.0
Varity_R
0.018
gMVP
0.43
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1538660; hg19: chr9-111641825; COSMIC: COSV65896197; API